Skip to main content
SpringerLink
Log in

Iatrogenic celiac and hepatic artery dissections during intra-arterial regional tumor therapies: a 16-year retrospective review

  • Interventional Radiology
  • Published:
Abdominal Radiology Aims and scope Submit manuscript

Abstract

Purpose

To identify the incidence and outcomes of iatrogenic celiac and hepatic artery dissections during transarterial therapies, including bland embolization, chemoembolization, radioembolization (TARE), and pre-TARE scintigraphic mapping.

Methods

The institution’s quality assessment database, electronic medical record, and picture archiving and communication system were reviewed to identify all patients who underwent transarterial locoregional therapy from 1/2001 to 7/2017 and to determine the incidence of iatrogenic dissection, to assess patency of the arteries after dissection, and to assess the ability to complete therapy.

Results

2253 patients underwent 3776 transarterial hepatic oncology procedures. Among 3776 procedures, 40 (1.1%) were associated with dissection of the visceral vasculature, affecting 39 patients (1.7%). The incidence of flow-limiting dissections was 0.3% (13/3776) and non-flow-limiting dissections was 0.7% (27/3776). After dissection, 68% (27/40) of treatments were completed the same day. Among the 13 aborted treatments, 8 (62%) were completed on a subsequent encounter. Follow-up imaging was obtained in 26 of 40 cases at median time of 63 days. Complete resolution of the dissection was seen in 15/26 cases (58%), near complete resolution (< 30% luminal narrowing) in 3/26 (12%), unchanged appearance of a non-flow-limiting dissection in 4/26 (15%), progressive luminal narrowing in 3/26 (12%), and complete occlusion in 1/26 (4%).

Conclusion

Iatrogenic dissections of visceral arteries rarely occur during tumor embolization procedures. 35/39 (90%) of patients underwent successful treatment despite the dissection.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Kwan SW, Kerlan RK, Jr., Sunshine JH (2010) Utilization of interventional oncology treatments in the United States. J Vasc Interv Radiol 21 (7):1054-1060. https://doi.org/10.1016/j.jvir.2010.02.028

    Article  PubMed  PubMed Central  Google Scholar 

  2. Sun JY, Yin T, Zhang XY, Lu XJ (2019) Therapeutic advances for patients with intermediate hepatocellular carcinoma. J Cell Physiol 234 (8):12116-12121. https://doi.org/10.1002/jcp.28019

    Article  CAS  PubMed  Google Scholar 

  3. Kouri BE (2018) Interventional Oncology: Optimizing Transarterial Therapies for the Treatment of Hepatic Malignancy. Tech Vasc Interv Radiol 21 (4):205-222. https://doi.org/10.1053/j.tvir.2018.07.002

    Article  PubMed  Google Scholar 

  4. Ma J, Gimenez JM, Sandow T, Devun D, Kirsch D, Gulotta P, Gilbert P, Kay D (2017) Intraarterial Liver-Directed Therapies: The Role of Interventional Oncology. Ochsner J 17 (4):412-416

    PubMed  PubMed Central  Google Scholar 

  5. Berger DH, Carrasco CH, Hohn DC, Curley SA (1995) Hepatic artery chemoembolization or embolization for primary and metastatic liver tumors: post-treatment management and complications. J Surg Oncol 60 (2):116-121

    Article  CAS  PubMed  Google Scholar 

  6. Tu J, Jia Z, Ying X, Zhang D, Li S, Tian F, Jiang G (2016) The incidence and outcome of major complication following conventional TAE/TACE for hepatocellular carcinoma. Medicine (Baltimore) 95 (49):e5606. https://doi.org/10.1097/md.0000000000005606

    Article  CAS  Google Scholar 

  7. Sakamoto I, Aso N, Nagaoki K, Matsuoka Y, Uetani M, Ashizawa K, Iwanaga S, Mori M, Morikawa M, Fukuda T, Hayashi K, Matsunaga N (1998) Complications associated with transcatheter arterial embolization for hepatic tumors. Radiographics 18 (3):605-619. https://doi.org/10.1148/radiographics.18.3.9599386

    Article  CAS  PubMed  Google Scholar 

  8. Peterson JL, Vallow LA, Johnson DW, Heckman MG, Diehl NN, Smith AA, Tzou KS, Paz-Fumagalli R, Kim S, Ko SJ, Daugherty LC, Kim GP, Brown N, Mori KW, Buskirk SJ (2013) Complications after 90Y microsphere radioembolization for unresectable hepatic tumors: An evaluation of 112 patients. Brachytherapy 12 (6):573-579. https://doi.org/10.1016/j.brachy.2013.05.008

    Article  PubMed  Google Scholar 

  9. Onizuka H, Sueyoshi E, Ishimaru H, Sakamoto I, Uetani M (2017) Arterial injury during transcatheter arterial chemoembolization for hepatocellular carcinoma: predictors of risk and outcome. Abdom Radiol (NY) 42 (10):2544-2550. https://doi.org/10.1007/s00261-017-1168-6

    Article  Google Scholar 

  10. Yoon DY, Park JH, Chung JW, Han JK, Han MC (1995) Iatrogenic dissection of the celiac artery and its branches during transcatheter arterial embolization for hepatocellular carcinoma: outcome in 40 patients. Cardiovasc Intervent Radiol 18 (1):16-19

    Article  CAS  PubMed  Google Scholar 

  11. Jung E, Shin JH, Kim JH, Yoon HK, Ko GY, Sung KB (2017) Arterial dissections during transcatheter arterial chemoembolization for hepatocellular carcinoma: a 19-year clinical experience at a single medical institution. Acta Radiol 58 (7):842-848. https://doi.org/10.1177/0284185116676654

    Article  PubMed  Google Scholar 

  12. Gee M, Soulen MC (2002) Chemoembolization for hepatic metastases. Tech Vasc Interv Radiol 5 (3):132-140. https://doi.org/10.1053/tvir.2002.36422

    Article  PubMed  Google Scholar 

  13. Chao C, Stavropoulos SW, Mondschein JI, Dagli M, Sudheendra D, Nadolski G, Soulen MC (2017) Effect of Substituting 50% Isovue for Sterile Water as the Delivery Medium for SIR-Spheres: Improved Dose Delivery and Decreased Incidence of Stasis. Clin Nucl Med 42 (3):176-179. https://doi.org/10.1097/rlu.0000000000001532

    Article  PubMed  Google Scholar 

  14. de Baere T, Arai Y, Lencioni R, Geschwind JF, Rilling W, Salem R, Matsui O, Soulen MC (2016) Treatment of Liver Tumors with Lipiodol TACE: Technical Recommendations from Experts Opinion. Cardiovasc Intervent Radiol 39 (3):334-343. https://doi.org/10.1007/s00270-015-1208-y

    Article  PubMed  Google Scholar 

  15. Ruutiainen AT, Soulen MC, Tuite CM, Clark TW, Mondschein JI, Stavropoulos SW, Trerotola SO (2007) Chemoembolization and bland embolization of neuroendocrine tumor metastases to the liver. J Vasc Interv Radiol 18 (7):847-855. https://doi.org/10.1016/j.jvir.2007.04.018

    Article  PubMed  Google Scholar 

  16. Brown DB, Nikolic B, Covey AM, Nutting CW, Saad WE, Salem R, Sofocleous CT, Sze DY, Society of Interventional Radiology Standards of Practice C (2012) Quality improvement guidelines for transhepatic arterial chemoembolization, embolization, and chemotherapeutic infusion for hepatic malignancy. J Vasc Interv Radiol 23 (3):287-294. https://doi.org/10.1016/j.jvir.2011.11.029

  17. Clark TW (2006) Complications of hepatic chemoembolization. Semin Intervent Radiol 23 (2):119-125. https://doi.org/10.1055/s-2006-941442

    Article  PubMed  PubMed Central  Google Scholar 

  18. Maeda N, Osuga K, Mikami K, Higashihara H, Onishi H, Nakaya Y, Tatsumi M, Hori M, Kim T, Tomoda K, Nakamura H (2008) Angiographic evaluation of hepatic arterial damage after transarterial chemoembolization for hepatocellular carcinoma. Radiat Med 26 (4):206-212. https://doi.org/10.1007/s11604-007-0216-5

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Interventional Radiology, Hospital of the University of Pennsylvania, 3400 Spruce Street, 1 Founders-MRI Education Center, Philadelphia, PA, 19104, USA

    Erica S. Alexander, Gregory J. Nadolski, Michael C. Soulen, S. William Stavropoulos, Stephen J. Hunt, Terence P. Gade, Maxim Itkin & Susan Shamimi-Noori

Authors
  1. Erica S. Alexander
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Gregory J. Nadolski
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Michael C. Soulen
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. S. William Stavropoulos
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Stephen J. Hunt
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Terence P. Gade
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Maxim Itkin
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Susan Shamimi-Noori
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Erica S. Alexander.

Ethics declarations

Conflict of interest

Erica Alexander declares that she has no conflicts of interest. Gregory Nadolski receives research support from Guerbet LCC and Teleflex. Michael Soulen receives research support from Guerbet LCC and BTG International, is a consultant for Guerbet LCC and Genentech, and is a proctor for Sirtex. S. William Stavropoulos is a consultant for Becton–Dickinson and receives research support from Cook and Sillajen. Stephen Hunt is a consultant for BTG and receives research grants from BTG, SIO, SIR, and RSNA. Terence Gade is a consultant for Trisalus and received an investigator initiation grant from Guerbet LLC. Max Itkin has no related conflicts to declare. Susan Shamimi-Noori is a proctor for Sirtex.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Alexander, E.S., Nadolski, G.J., Soulen, M.C. et al. Iatrogenic celiac and hepatic artery dissections during intra-arterial regional tumor therapies: a 16-year retrospective review. Abdom Radiol 44, 3480–3485 (2019). https://doi.org/10.1007/s00261-019-02203-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00261-019-02203-z

Keywords

Search

Navigation